Andrew Salama, DDS
Oral & Maxillofacial Surgery · Boston, MANPI 1386788479
Payments from drug & device makers
What this record shows
6 manufacturers reported payments, led by Kls-martin L.p. at 49.1% of the total. Reporting peaked in 2024 at $1,987 and has fallen 83.8% since, to $321 in 2025.
Across 31 payments — averaging $136.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kls-martin L.p.$2K
- Stryker$2K
- Dilon Technologies, Inc.$153
- Lightforce Orthodontics, Inc.$130
- Axogen$26
- Johnson & Johnson$16
What the payments were for
- Travel & lodging$2,42057%
- Food & beverage$1,79743%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kls-martin L.p. | 12 | $2,072 |
| Stryker | 15 | $1,821 |
| Dilon Technologies, Inc. | 1 | $153 |
| Lightforce Orthodontics, Inc. | 1 | $130 |
| Axogen | 1 | $26 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,218 in reported general payments places this provider in the 85th percentile of 247 oral & maxillofacial surgery providers in Massachusetts.
See all oral & maxillofacial surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 25 | $74 |
| Amoxicillin | 12 | $43 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Boston
- Briana BurrisBoston$67K
- Cory ResnickBoston$65K
- Daniel ChoiBoston$48K
- David ChangBoston$42K
- Miguel VidalBoston$25K
- Hussam BatalBoston$19K
- Amir NaimiBoston$16K
- Steven ScrivaniBoston$15K
- Andrew GrossBoston$12K
- Jeffrey HajibandehBoston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.